Delivery Order SPE2DB22D9239-SPE2DB25FDL96
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $38,347.10 to the woman-owned small business DMS Pharmaceutical Group Inc. based in Park Ridge, Illinois. The order is for the pharmaceutical product Rituxan 500 mg/50 ml vial and has a completion date of February 28, 2023. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,965.88 by the Defense Logistics Agency on August 7, 2025. The contract calls for the delivery of Rituxan 500 mg/50 ml vials, a biologic medication commonly used in oncology and rheumatology treatments. This delivery order was issued without a set-aside designation, and performance is scheduled for completion by August...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,965.88 by the Defense Logistics Agency (DLA) on August 21, 2025. The delivery order covers Rituxan 500 mg/50 ml vials for delivery to Park Ridge, Illinois, with a firm fixed-price contract type and an ultimate completion date of September 12, 2025. This award carries no set-aside designation, allowing the vendor to compete on an open basis...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,345.85 contract is for the supply of Rituxan 500 mg/50 ml vials. This delivery order is issued against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA under the SPE2DB program, which enables the agency to order a broad range of pharmaceutical...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $29,829.40 for Rituxan 500 mg/50 ml vials. The delivery order was issued on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. This award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $5,965.88 to DMS Pharmaceutical Group Inc. for the supply of Rituxan 500 mg/50 mL vials on August 12, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, which is valued at approximately $500 million and extends through November 2026. The award carries no set-aside designation, allowing the woman-owned small business based in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $17,897.64 on June 2, 2025, for the supply of Rituxan 500 mg/50 ml vials. The contract is firm fixed-price with an ultimate completion date of June 24, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency...
- The Defense Logistics Agency (DLA) awarded a $32,045.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4558921358 units of the pharmaceutical product Rituxan (500 mg/50 mL vial, 50 mL) to support the medical supply needs of military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $12,276.68 contract is for the supply of Rituxan 500 mg/50 ml vial, a pharmaceutical product used for medical treatment. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The $15,345.85 contract is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML, with a completion date of March 5, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, to provide a wide range of pharmaceutical products to military health...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL96Delivery Order
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Rituxan 500 mg/50 ml vials. This firm fixed-price delivery order, valued at $11,931.76, was awarded on September 17, 2025, with an ultimate completion date of October 8, 2025. The contract does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. Performance will occur at the vendor's Park Ridge, Illinois location. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026. The IDC establishes a comprehensive pharmaceutical supply agreement enabling the agency to procure branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain positions it to fulfill the specialized pharmaceutical distribution needs of Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 9/17/25 |